- Home
- FGBI vs ALEC Comparison
FGBI vs ALEC Comparison
Compare FGBI & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGBI
- ALEC
- Stock Information
- Founded
- FGBI 1934
- ALEC 2013
- Country
- FGBI United States
- ALEC United States
- Employees
- FGBI N/A
- ALEC N/A
- Industry
- FGBI Savings Institutions
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FGBI Finance
- ALEC Health Care
- Exchange
- FGBI Nasdaq
- ALEC Nasdaq
- Market Cap
- FGBI 121.5M
- ALEC 124.0M
- IPO Year
- FGBI N/A
- ALEC 2019
- Fundamental
- Price
- FGBI $7.84
- ALEC $2.52
- Analyst Decision
- FGBI
- ALEC Buy
- Analyst Count
- FGBI 0
- ALEC 8
- Target Price
- FGBI N/A
- ALEC $4.50
- AVG Volume (30 Days)
- FGBI 3.6K
- ALEC 1.6M
- Earning Date
- FGBI 08-18-2025
- ALEC 08-07-2025
- Dividend Yield
- FGBI 0.50%
- ALEC N/A
- EPS Growth
- FGBI N/A
- ALEC N/A
- EPS
- FGBI N/A
- ALEC N/A
- Revenue
- FGBI $59,070,000.00
- ALEC $81,130,000.00
- Revenue This Year
- FGBI N/A
- ALEC N/A
- Revenue Next Year
- FGBI $3.38
- ALEC $319.82
- P/E Ratio
- FGBI N/A
- ALEC N/A
- Revenue Growth
- FGBI N/A
- ALEC 46.77
- 52 Week Low
- FGBI $6.56
- ALEC $0.87
- 52 Week High
- FGBI $15.25
- ALEC $6.37
- Technical
- Relative Strength Index (RSI)
- FGBI 40.14
- ALEC 67.40
- Support Level
- FGBI $7.70
- ALEC $2.03
- Resistance Level
- FGBI $8.08
- ALEC $2.50
- Average True Range (ATR)
- FGBI 0.19
- ALEC 0.25
- MACD
- FGBI -0.03
- ALEC 0.04
- Stochastic Oscillator
- FGBI 19.67
- ALEC 96.49
About FGBI First Guaranty Bancshares Inc.
First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.